Natera, Inc.
Clinical trials sponsored by Natera, Inc., explained in plain language.
-
Blood test could spare some breast cancer patients from extra drugs
Disease control Recruiting nowThis study looks at whether a blood test (Signatera) can help decide when to start a targeted therapy (CDK4/6 inhibitor) in people with intermediate-risk HR+ HER2- breast cancer. About 725 participants will be monitored with regular blood draws; if the test detects cancer DNA, th…
Phase: NA • Sponsor: Natera, Inc. • Aim: Disease control
Last updated May 14, 2026 12:04 UTC
-
Could a simple blood test catch colon cancer early? 25,000 volunteers needed
Diagnosis Recruiting nowThis study is testing a new blood test (the Natera CRC Screening Test) to see how well it can detect colorectal cancer and advanced growths in people at average risk. About 25,000 adults aged 40 and older who are already planning a colonoscopy will provide blood samples. The resu…
Sponsor: Natera, Inc. • Aim: Diagnosis
Last updated May 16, 2026 21:18 UTC
-
New blood test could spot genetic diseases before birth
Diagnosis Recruiting nowThis study is working to create a simple blood test for pregnant women that can check for serious genetic conditions like cystic fibrosis, spinal muscular atrophy, and sickle cell disease in their unborn baby. Researchers will collect blood samples from 4,000 pregnant women who a…
Sponsor: Natera, Inc. • Aim: Diagnosis
Last updated May 16, 2026 21:16 UTC
-
Thousands of cancer patients help build better detection tests
Knowledge-focused Recruiting nowThis study collects blood and leftover tissue samples from 9,600 adults with different types of cancer, such as breast, lung, and pancreatic cancer. Researchers will use these samples to improve tests that look for tiny bits of cancer DNA in the blood, which may help detect if ca…
Sponsor: Natera, Inc. • Aim: Knowledge-focused
Last updated May 13, 2026 15:58 UTC